Health Catalyst, Inc. (HCAT) Financial Statements
Health Catalyst, Inc. (HCAT) reported trailing twelve-month revenue of $292.2M (down 7.5% year on year) and net income of -$264.8M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $7.9M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
HCATHealth Catalyst, Inc.Follow HCAT — free
—
Price chart with a free account
- Market cap
- 127.2M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 154.9 | 188.8 | 241.9 | 276.2 | 295.9 | 306.6 | 311.1 | 292.2 | |
| Gross profit | 79.6 | 90.8 | 117.6 | 133.2 | 131.8 | 140.8 | 151.7 | 147.5 | |
| Research & development | 46.3 | 53.5 | 62.7 | 75.7 | 72.6 | 58.0 | 49.8 | 43.0 | |
| Operating income | -54.9 | -96.1 | -143.7 | -140.0 | -126.9 | -69.8 | -160.9 | -246.5 | |
| Pre-tax income | -60.0 | -116.2 | -160.1 | -141.7 | -117.8 | -69.2 | -177.3 | -263.7 | |
| Income tax | 0.1 | -1.2 | -6.9 | -4.3 | 0.4 | 0.3 | 0.7 | 1.1 | |
| Net income | -60.1 | -115.0 | -153.2 | -137.4 | -118.1 | -69.5 | -178.0 | -264.8 | |
| Diluted EPS ($) | -12.86 | -2.91 | -3.23 | -2.63 | -2.09 | -1.15 | -2.55 | -3.70 | |
| Diluted shares (mn) | — | — | 47.5 | 54.1 | 56.4 | 60.2 | 69.9 | — |
USD millions · SEC XBRL
Health Catalyst, Inc. — questions
- What is Health Catalyst, Inc.'s revenue?
- $292.2M over the twelve months to 2026-06-30, down 7.5% year on year, from its 10-Q and 10-K filings.
- What is Health Catalyst, Inc.'s net income?
- -$264.8M over the twelve months to 2026-06-30.
- What is Health Catalyst, Inc.'s free cash flow?
- $7.9M over the twelve months to 2026-06-30.
- What are Health Catalyst, Inc.'s diluted earnings per share?
- $-3.70 over the twelve months to 2026-06-30.
Every figure on this page comes from Health Catalyst, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.